No Data
No Data
Check Out What Whales Are Doing With MRNA
Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).And retail traders should know.We noticed this today when the trades showed up on publicly available
Moderna Insider Sold Shares Worth $1,842,651, According to a Recent SEC Filing
Noubar Afeyan, Director, on July 17, 2024, sold 15,000 shares in Moderna (MRNA) for $1,842,651. Following the Form 4 filing with the SEC, Afeyan has control over a total of 6,886,164 shares of the
Here Are Big Pharma's Leading Blockbuster Makers
Moderna (NASDAQ:MRNA) Shareholders Have Earned a 54% CAGR Over the Last Five Years
Decoding Moderna's Options Activity: What's the Big Picture?
Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna.Looking at options history for Moderna (NASDAQ:MRNA) we detected 8 trades.If we consider the specifics of each
Jefferies Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $180
Jefferies analyst Michael Yee maintains $Moderna(MRNA.US)$ with a buy rating, and maintains the target price at $180.According to TipRanks data, the analyst has a success rate of 45.8% and a total